Investor FAQs
Show All
Investor FAQs
When was Orphazyme founded?
The company was founded in 2009 based on a scientific discovery on the function of Heat-Shock Proteins (HSPs) by Thomas Kirkegaard Jensen, co-Founder and Chief Scientific Officer, and Professor Marja Jäättelä that was published in the scientific journal Nature.
Where is Orphazyme located?
Orphazyme is Headquartered in Denmark (Copenhagen) and has subsidiaries in Switzerland (Zug) and the United States (Chicago).
When did the company go public?
The company listed on Nasdaq Copenhagen A/S in Denmark in November 2017, and on Nasdaq Select Global Market in the US in September 2020. In March 2022, the Company voluntary delisted ADSs representing its ordinary shares from the Nasdaq Global Select Market in the United States.
On which Stock markets is Orphazyme traded and what are the company tickers?
Nasdaq Copenhagen A/S in Denmark, ticker symbol ORPHA.
What disease areas does Orphazyme focus on and are any Orphazyme products marketed?
Until recently, Orphazyme was focused on the research and development of novel therapeutics for neurodegenerative diseases, such as Niemann Pick disease type C (NPC).
In May 2022, substantially all the company’s assets and business activities, including those relating to the development and approval of arimoclomol, were sold to KemPharm Denmark A/S, a wholly owned subsidiary of KemPharm Inc.
In May 2022, substantially all the company’s assets and business activities, including those relating to the development and approval of arimoclomol, were sold to KemPharm Denmark A/S, a wholly owned subsidiary of KemPharm Inc.
Does Orphazyme pay a dividend?
Orphazyme has never declared or paid any cash dividends and does not anticipate doing so in the foreseeable future. The company intends to retain all available funds and any future earnings to fund the development of its business.
Who are the company’s Auditors?
Ernst and Young.
Who should I contact regarding shareholder and investor relations questions?
Please contact Anders Vadsholt, Chief Executive Officer & Chief Financial Officer, at afv@orphazyme.com
I am a shareholder, how can I find more information on my shareholding?
As a shareholder you can access the Orphazyme Shareholder Portal here: https://portal.computershare.dk/portal/index.asp?page=login&asident=22035&caller=GFList&lan=EN
Where can I find information about Orphazyme ADSs previously listed on Nasdaq Global Select Market in the US?
You can find an FAQ on the previous ADS here